First-in-human safety and pharmacokinetics of MK-7602, the antimalarial inhibitor of plasmepsins IX/X, in single- and multiple-ascending-dose studies
MK-7602(一种抗疟疾药物,可抑制疟原虫蛋白酶IX/X)的首次人体安全性和药代动力学研究(单次和多次递增剂量研究)
期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/aac.01261-25
Stanley, Susan E; Carstens, Russ P; Liberti, Maria V; Eertmans, Ward; Vranckx, Myrthel; Longo, Diane; Ghosal, Nairita; Vavrek, Marissa; Olsen, David B; Cowman, Alan F; Reynders, Tom; Cilissen, Caroline; Laethem, Tine; Rottey, Sylvie; Robbins, Jonathan A; Stoch, S Aubrey; Nussbaum, Jesse